Upcoming Events

Mesa redonda com a participação de líderes da área de Assuntos Regulatórios de medicamentos e produtos para saúde para discussão de como a liderança pode se preparar para os desafios futuros.

Free educational event focusing on topics of interest to UK pharmaceuticals and medical devices, including IVDs.

In de afgelopen maanden zijn er diverse voorstellen gedaan vanuit de Europese Commissie voor aanpassingen in wet en regelgeving die impact (gaan) hebben op alle stakeholders die met medische hulpmiddelen en in-vitro diagnostica te maken hebben. Tijdens onze 43e sessie gaan we een dag wijden aan een selectie van de onderwerpen. Hierbij komen vertegenwoordigers van de overheden en Notified Bodies aan het woord, en wordt de impact voor fabrikanten en ziekenhuizen bekeken. Daartoe zijn panels en parallel sessies gepland.

RAQA Leadership Retreat 2026 Join the RAPS Switzerland Chapter RAQA Leadership Retreat 2026 in the Swiss Alps for two days of expert-led discussions, peer exchange, and practical insights designed for today's RA/QA professionals. 2000CHF, 1800CHF for early birds until end of July 2026

Participating in RAPS France LNG in person social event is the perfect opportunity to expand your network and share your insights on topics most relevant to health products. Interested CE marking process? You will also have the opportunity to speak to GMED team who kindly sponsored this event.

Join RAPS Twin Cities for an interactive keynote on what separates regulatory leaders who truly move the enterprise, with Jackie Peterson, PCC, CEO of Lift Bridge Leadership. Leave with one committed action.

Join RAPS Philadelphia for an in-person panel on pediatric rare disease drug development. Explore evolving regulatory strategies, innovative evidence generation, patient engagement, and practical approaches to advancing therapies for children.

Health Canada Medical Device Single Audit Program (MDSAP) Advancements

Join us for a networking and recruitment series across multiple in-person events. Meet regulatory professionals, connect with chapter leaders, and learn about ambassador and leadership roles.

Join RAPS Philadelphia for a cross-functional look at leveraging business and legal topics to supercharge your regulatory intelligence, drive product development insight, and communicate value effectively across your key stakeholders. In a program sure to be insightful for regulatory and legal professionals alike, an expert group of panelists will discuss strategies and practical takeaways to bring back to your business.

Join SGS & RAPS for a dynamic full-day event focused on advancing medical technology and providing greater protection for patients, featuring multiple FDA speakers and medical device industry experts.

Building on the momentum of the inaugural “From Classroom to Career” panel held in May 2026, the RAPS NC Local Networking Group returns to continue the conversation on clinical research and regulatory affairs workforce development in North Carolina and beyond. This second installment brings together industry leaders, academic faculty, and emerging professionals to revisit the state of regulatory and clinical research education: what progress has been made since the spring discussion, where gaps still persist, and what new curricular innovations are shaping the pipeline of talent entering the field. Panelists will examine how academic programs are adapting to industry demand, the role of mentorship and experiential learning in preparing students for regulatory careers, and strategies for strengthening the connection between classroom instruction and real-world practice. This event is designed for clinical research professionals, regulatory affairs practitioners, academic faculty, students, and anyone invested in shaping the educational infrastructure that supports these fields.

Join the NJ RAPS Chapter as we host a virtual session on how agencies have responded to Humanized Mouse (huMouse) justifications in practice, and how to position these models across development stages. The goal is to help attendees make better-informed decisions about when huMouse models strengthen a regulatory submission — and when they don't.

Explore FDA standards, ASCA, QMSR, ISO 13485, MDSAP, quality systems, manufacturing controls, and inspection readiness across medical devices, drugs, and biologics. Hear from FDA & industry experts

Navigating biological evaluation requirements can be complex and resource-intensive without a clear, forward-looking strategy grounded in current regulations. This session will provide an in-depth overview of the latest updates to ISO 10993-1:2025 and upcoming technical specifications designed to help manufacturers and assessors effectively implement these new expectations. Attendees will gain insight into how global regulatory authorities are recognizing and aligning with these changes, as well as the risk assessment and management principles driving key revisions. Finally, the session will outline strategic planning practices that can be applied early in the product development process to streamline biological evaluation activities, minimize delays, and ensure full compliance with ISO 10993-1:2025.

Explore the dynamics at FDA and why neither “naive harmony” nor inevitable conflict are good approaches to interactions with FDA. Learn effective techniques for strategic preparation and communication to work with FDA to avoid escalation and when needed how to escalate matters within FDA.

Please join us for this informal event meant to connect our chapter members to each other and build our professional networks.